Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy
In delivering their verdict on March 16, a jury in the Chicago DePuy Hip trial ruled in Johnson & Johnson and DePuy’s favor. In an article from the New York Times, the jury released a verdict stating that neither Johnson & Johnson nor DePuy engaged in a misleading marketing campaign to promote the metal-on-metal hip implant. In contrast to the Chicago DePuy Hip trial, in the first DePuy ASR Hip lawsuit to go to trial in California, the plaintiff Loren Kransky was awarded a compensatory award of $8.3 million. Continue Reading
USA Today Editorial Decries Johnson & Johnson and DePuy for Failure to Properly Address Defective DePuy ASR Hip Implant
Submit Your Claim A recent USA Today editorial piece published on March 24 takes the position that Johnson & Johnson and DePuy mismanaged the development and marketing efforts behind their DePuy ASR Hip Replacement system. Stemming from our own investigation into the DePuy ASR Hip implant, lawyers at Carey Danis & Lowe agree that neither Johnson & Johnson nor their subsidiary, DePuy, correctly addressed any of the warning signs. According to the USA Today opinion piece, Johnson & Johnson and DePuy ignored red flags, and as a result, did Continue Reading
DePuy President Testifies in Strum v. DePuy: DePuy Defense Asserts DePuy ASR Hip Recall about Revision Rates not Defective Product
Submit Your Claim DePuy President, Andrew Ekdahl, delivered testimony during day three of Strum v. DePuy, a case being heard in a Chicago state court. The DePuy ASR Hip lawsuit involves Carol Strum, whose lawsuit against DePuy is the second of 10,750 DePuy ASR Hip lawsuit to go to trial. According to Ekdahl, DePuy initiated the DePuy ASR Hip recall due to the high rates of revision associated with the metal-on-metal hip implant. However, according to a Businessweek article about the Chicago case, the medical device manufacturer’s defense attorney, Continue Reading
Second DePuy ASR Hip Trial Begins in Chicago Court
Submit Your Claim On the heels of Johnson & Johnson’s loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11 in the Circuit Court of Cook County in Chicago, Illinois. The case is Strum v. DePuy, and involves the plaintiff, Carol Strum, a 54 year old nurse and Illinois resident. After receiving a DePuy ASR Hip implant, Strum claims that her implant proved defective after only three years. Strum’s case is the second DePuy ASR Hip Continue Reading
Kransky v. DePuy Jury Awards Plaintiff $8.3 Million Compensatory Award
Submit Your Claim On March 8, the jury in Kransky v. DePuy awarded the plaintiff in the case a compensatory award of $8.3 million. The compensatory damages to be paid to the plaintiff, Loren Kransky, by Johnson & Johnson cover Kransky’s pain and suffering after receiving an implant of the DePuy ASR Hip. However, the jury decided against awarding punitive damages because they believe that Johnson & Johnson and DePuy had supplied sufficient warning about the health risks involved with the use of the DePuy ASR Hip implant. Kransky Continue Reading
Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
Submit Your Claim Published March 19, 2013 by PR Web St. Louis, Missouri (PRWEB) March 19, 2013 With defective medical device lawyers currently investigating DePuy ASR Hip Replacement system cases, Carey Danis & Lowe is optimistic about the future of DePuy ASR Hip lawsuits that go to trial. Kransky v. DePuy, a case being heard in a California Superior Court in Los Angeles, involved the plaintiff, Loren Kransky, and resulted in Kransky receiving a compensatory award of $8.3 million, according to a New York Times report on the [DePuy trial]. Though the Continue Reading
Gynecare Prolift Lawsuit News: Gross v. Gynecare Jury Rules that Johnson & Johnson to Pay Over $7 Million in Punitive Damages
Submit Your Claim Last week, Carey Danis & Lowe released an update on the Gynecare Prolift trial in New Jersey, and wrote that Linda Gross was awarded $3.35 million in a case involving Johnson & Johnson’s defective Gynecare Prolift vaginal mesh. On February 25, the jury announced Gross’s compensatory award, and later also ruled that Johnson & Johnson should pay $7.76 million in punitive damages on top of the compensatory award. Gross is a resident of South Dakota, and a former nurse, who received an implant of Johnson & Continue Reading
Plaintiff Awarded $3.35 Million in Gynecare Prolift Lawsuit: Encouraging Verdict for Victims of Defective Vaginal Mesh Products
Submit Your Claim In a Gynecare Prolift vaginal mesh lawsuit being heard in a New Jersey Superior court, the plaintiff, Linda Gross, was awarded $3.35 million. The trial, overseen by Judge Carol Higbee in Atlantic City, New Jersey, involves a South Dakota resident who claims to have been in severe and unmitigated pain and to have endured 18 operations to remove and repair damages caused by Ethicon’s Gynecare Prolift vaginal mesh. Though the jury was split in their final decision in Gross’s case, according to a Bloomberg News report, Continue Reading
Closing Arguments Delivered in Gynecare Prolift Trial in New Jersey
Submit Your Claim A decision by the jury should be delivered soon regarding a lawsuit filed in New Jersey against Johnson & Johnson and Ethicon, the developer and manufacturer of the Gynecare Prolift vaginal mesh product. Late last week, both sides shared their closing arguments, which leaves the jury to deliberate on the testimony presented before them since the start of the trial on January 10, 2013. The case is Gross v. Gynecare Inc., and is being heard in a SuperiorCourtofAtlanticCounty in Atlantic City, New Jersey by Judge Carol Continue Reading
DePuy ASR Hip Trial Update: DePuy Marketing Director Voiced Concerns about DePuy ASR Hip Implant and Advised Recall
Submit Your Claim The first of 10,000 DePuy ASR Hip lawsuits is on trial in a California Superior Court in Los Angeles County. The trial, Kransky v. DePuy, continues to move forward with testimony, most recently from a DePuy marketing executive. he testimony delivered late last week concerned a Johnson & Johnson director of hip marketing, Paul Berman, who wrote an email voicing concerns about the safety of the DePuy ASR Hip Replacement system, and advised a recall. Berman’s email was sent out on March 14, 2010. According to Continue Reading
